Bristol-Myers Squibb
BMY
#193
Rank
NZ$199.92 B
Marketcap
NZ$97.90
Share price
0.40%
Change (1 day)
20.42%
Change (1 year)

P/S ratio for Bristol-Myers Squibb (BMY)

P/S ratio as of June 2026 (TTM): 2.41

According to Bristol-Myers Squibb's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.30. At the end of 2026 the company had a P/S ratio of 2.47.

P/S ratio history for Bristol-Myers Squibb from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20262.479.17%
20252.26-6.77%
20242.424.41%
20232.32-30%
20223.3111.08%
20212.98-9.5%
20203.30-39.73%
20195.4746.19%
20183.74-22.49%
20174.83-3.97%
20165.03-27.14%
20156.9012.28%
20146.1515.44%
20135.3276.57%
20123.017.25%
20112.8121.74%
20102.31-10.66%
20092.5815.66%
20082.23-21.96%
20072.86-0.67%
20062.8823.12%
20052.34-17.55%
20042.847.6%
20032.645.74%
20022.50-52.16%
20015.22

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.00 149.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.17 115.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.36-2.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
6.57 172.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
14.1 486.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
5.13 113.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.91-20.59%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
2.98 23.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.50 87.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.61 91.67%๐Ÿ‡ฌ๐Ÿ‡ง UK